Neuropsychiatric Lupus Erythematosus: Future Directions and Challenges; a Systematic Review and Survey
Autor(a) principal: | |
---|---|
Data de Publicação: | 2020 |
Outros Autores: | , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Clinics |
Texto Completo: | https://www.revistas.usp.br/clinics/article/view/168842 |
Resumo: | This study aimed to systematically review neuropsychiatric lupus erythematosus (NPSLE) and establish a simplified diagnostic criterion for NPSLE. Publications from 1994 to 2018 in the database (Wanfang data (http://www.wanfangdata.com.cn/index.html) and China National Knowledge Internet (http://www.cnki.net)) were included. In total, 284 original case reports and 24 unpublished cases were collected, and clinical parameters were analyzed. An attempt was made to develop a set of simplified diagnostic criteria for NPSLE based on cases described in the survey and literature; moreover, and pathophysiology and management guidelines were studied. The incidence rate of NPSLE was estimated to be 12.4% of SLE patients in China. A total of 408 NPSLE patients had 652 NP events, of which 91.2% affected the central nervous system and 8.8% affected the peripheral nervous system. Five signs (manifestations, disease activity, antibodies, thrombosis, and skin lesions) showed that negative and positive predictive values were more than 70%, included in the diagnostic criteria. The specificity, accuracy, and positive predictive value (PPV) of the revised diagnostic criteria were significantly higher than those of the American College of Rheumatology (ACR) criteria (w2=13.642, 15.591, 65.010, po0.001). The area under the curve (AUC) for revised diagnostic criteria was 0.962 (standard error=0.015, 95% confidence intervals [CI] =0.933–0.990), while the AUC for the ACR criteria was 0.900 (standard error=0.024, 95% CI=0.853–0.946). The AUC for the revised diagnostic criteria was different from that for the ACR criteria (Z=2.19, po0.05). Understanding the pathophysiologic mechanisms leading to NPSLE is essential for the evaluation and design of effective interventions. The set of diagnostic criteria proposed here represents a simplified, reliable, and costeffective approach used to diagnose NPSLE. The revised diagnostic criteria may improve the accuracy rate for diagnosing NPSLE compared to the ACR criteria. |
id |
USP-19_3eb2d54ef1387f41831a9ae66363e247 |
---|---|
oai_identifier_str |
oai:revistas.usp.br:article/168842 |
network_acronym_str |
USP-19 |
network_name_str |
Clinics |
repository_id_str |
|
spelling |
Neuropsychiatric Lupus Erythematosus: Future Directions and Challenges; a Systematic Review and SurveyNeuropsychiatric Lupus ErythematosusDiagnostic CriteriaManagementThis study aimed to systematically review neuropsychiatric lupus erythematosus (NPSLE) and establish a simplified diagnostic criterion for NPSLE. Publications from 1994 to 2018 in the database (Wanfang data (http://www.wanfangdata.com.cn/index.html) and China National Knowledge Internet (http://www.cnki.net)) were included. In total, 284 original case reports and 24 unpublished cases were collected, and clinical parameters were analyzed. An attempt was made to develop a set of simplified diagnostic criteria for NPSLE based on cases described in the survey and literature; moreover, and pathophysiology and management guidelines were studied. The incidence rate of NPSLE was estimated to be 12.4% of SLE patients in China. A total of 408 NPSLE patients had 652 NP events, of which 91.2% affected the central nervous system and 8.8% affected the peripheral nervous system. Five signs (manifestations, disease activity, antibodies, thrombosis, and skin lesions) showed that negative and positive predictive values were more than 70%, included in the diagnostic criteria. The specificity, accuracy, and positive predictive value (PPV) of the revised diagnostic criteria were significantly higher than those of the American College of Rheumatology (ACR) criteria (w2=13.642, 15.591, 65.010, po0.001). The area under the curve (AUC) for revised diagnostic criteria was 0.962 (standard error=0.015, 95% confidence intervals [CI] =0.933–0.990), while the AUC for the ACR criteria was 0.900 (standard error=0.024, 95% CI=0.853–0.946). The AUC for the revised diagnostic criteria was different from that for the ACR criteria (Z=2.19, po0.05). Understanding the pathophysiologic mechanisms leading to NPSLE is essential for the evaluation and design of effective interventions. The set of diagnostic criteria proposed here represents a simplified, reliable, and costeffective approach used to diagnose NPSLE. The revised diagnostic criteria may improve the accuracy rate for diagnosing NPSLE compared to the ACR criteria.Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2020-04-16info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfapplication/xmlhttps://www.revistas.usp.br/clinics/article/view/16884210.6061/clinics/2020/e1515Clinics; Vol. 75 (2020); e1515Clinics; v. 75 (2020); e1515Clinics; Vol. 75 (2020); e15151980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/168842/160251https://www.revistas.usp.br/clinics/article/view/168842/160252Copyright (c) 2020 Clinicsinfo:eu-repo/semantics/openAccessZhang, YongwenHan, HuanhuanChu, Lanfang2020-04-16T19:06:58Zoai:revistas.usp.br:article/168842Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2020-04-16T19:06:58Clinics - Universidade de São Paulo (USP)false |
dc.title.none.fl_str_mv |
Neuropsychiatric Lupus Erythematosus: Future Directions and Challenges; a Systematic Review and Survey |
title |
Neuropsychiatric Lupus Erythematosus: Future Directions and Challenges; a Systematic Review and Survey |
spellingShingle |
Neuropsychiatric Lupus Erythematosus: Future Directions and Challenges; a Systematic Review and Survey Zhang, Yongwen Neuropsychiatric Lupus Erythematosus Diagnostic Criteria Management |
title_short |
Neuropsychiatric Lupus Erythematosus: Future Directions and Challenges; a Systematic Review and Survey |
title_full |
Neuropsychiatric Lupus Erythematosus: Future Directions and Challenges; a Systematic Review and Survey |
title_fullStr |
Neuropsychiatric Lupus Erythematosus: Future Directions and Challenges; a Systematic Review and Survey |
title_full_unstemmed |
Neuropsychiatric Lupus Erythematosus: Future Directions and Challenges; a Systematic Review and Survey |
title_sort |
Neuropsychiatric Lupus Erythematosus: Future Directions and Challenges; a Systematic Review and Survey |
author |
Zhang, Yongwen |
author_facet |
Zhang, Yongwen Han, Huanhuan Chu, Lanfang |
author_role |
author |
author2 |
Han, Huanhuan Chu, Lanfang |
author2_role |
author author |
dc.contributor.author.fl_str_mv |
Zhang, Yongwen Han, Huanhuan Chu, Lanfang |
dc.subject.por.fl_str_mv |
Neuropsychiatric Lupus Erythematosus Diagnostic Criteria Management |
topic |
Neuropsychiatric Lupus Erythematosus Diagnostic Criteria Management |
description |
This study aimed to systematically review neuropsychiatric lupus erythematosus (NPSLE) and establish a simplified diagnostic criterion for NPSLE. Publications from 1994 to 2018 in the database (Wanfang data (http://www.wanfangdata.com.cn/index.html) and China National Knowledge Internet (http://www.cnki.net)) were included. In total, 284 original case reports and 24 unpublished cases were collected, and clinical parameters were analyzed. An attempt was made to develop a set of simplified diagnostic criteria for NPSLE based on cases described in the survey and literature; moreover, and pathophysiology and management guidelines were studied. The incidence rate of NPSLE was estimated to be 12.4% of SLE patients in China. A total of 408 NPSLE patients had 652 NP events, of which 91.2% affected the central nervous system and 8.8% affected the peripheral nervous system. Five signs (manifestations, disease activity, antibodies, thrombosis, and skin lesions) showed that negative and positive predictive values were more than 70%, included in the diagnostic criteria. The specificity, accuracy, and positive predictive value (PPV) of the revised diagnostic criteria were significantly higher than those of the American College of Rheumatology (ACR) criteria (w2=13.642, 15.591, 65.010, po0.001). The area under the curve (AUC) for revised diagnostic criteria was 0.962 (standard error=0.015, 95% confidence intervals [CI] =0.933–0.990), while the AUC for the ACR criteria was 0.900 (standard error=0.024, 95% CI=0.853–0.946). The AUC for the revised diagnostic criteria was different from that for the ACR criteria (Z=2.19, po0.05). Understanding the pathophysiologic mechanisms leading to NPSLE is essential for the evaluation and design of effective interventions. The set of diagnostic criteria proposed here represents a simplified, reliable, and costeffective approach used to diagnose NPSLE. The revised diagnostic criteria may improve the accuracy rate for diagnosing NPSLE compared to the ACR criteria. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020-04-16 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.revistas.usp.br/clinics/article/view/168842 10.6061/clinics/2020/e1515 |
url |
https://www.revistas.usp.br/clinics/article/view/168842 |
identifier_str_mv |
10.6061/clinics/2020/e1515 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://www.revistas.usp.br/clinics/article/view/168842/160251 https://www.revistas.usp.br/clinics/article/view/168842/160252 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2020 Clinics info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2020 Clinics |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf application/xml |
dc.publisher.none.fl_str_mv |
Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo |
publisher.none.fl_str_mv |
Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo |
dc.source.none.fl_str_mv |
Clinics; Vol. 75 (2020); e1515 Clinics; v. 75 (2020); e1515 Clinics; Vol. 75 (2020); e1515 1980-5322 1807-5932 reponame:Clinics instname:Universidade de São Paulo (USP) instacron:USP |
instname_str |
Universidade de São Paulo (USP) |
instacron_str |
USP |
institution |
USP |
reponame_str |
Clinics |
collection |
Clinics |
repository.name.fl_str_mv |
Clinics - Universidade de São Paulo (USP) |
repository.mail.fl_str_mv |
||clinics@hc.fm.usp.br |
_version_ |
1800222765017464832 |